Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Development and Engineering Services That Push Innovations to Market: MarketScale Mornings

On this episode of MarketScale Mornings, hosts Taylor Bagley and Voice of B2B Daniel Litwin were joined by Paragon Innovations CEO and Founder Mike Wilkinson.   Founded in 1990 and counting companies like 3M, Hitachi, Medtronic, Motorola, and Siemens as clients, Paragon is one of the nation’s leading providers of turn-key product development and innovation…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share
Development and Engineering Services That Push Innovations to Market: MarketScale Mornings

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

On this episode of MarketScale Mornings, hosts Taylor Bagley and Voice of B2B Daniel Litwin were joined by Paragon Innovations CEO and Founder Mike Wilkinson.

Founded in 1990 and counting companies like 3M, Hitachi, Medtronic, Motorola, and Siemens as clients, Paragon is one of the nation’s leading providers of turn-key product development and innovation and engineering services. With projects that span anywhere from Class I and Class II medical devices to cellular-based hunting cameras and even a new cellular-, GPS-, WiFi- and Bluetooth-enabled dog collar called Link that not only tracks man’s best friend, but features sensors that monitor a pet’s health and wellness and offers connectivity to the vet, Paragon has worked with a vast variety of industries—both established corporations and new startups—helping to push unique and highly creative innovations and ideas to market.

Wilkinson states that while some products may have similar systems that make it easier for them to engineer, Paragon’s ability to handle innovations that differ profoundly from industry to industry and product to product comes from truly listening to the customer and learning first-hand about their requirements.

“Our customers—they know their industry,” he explained. “What makes us unique from a lot of our competitors—both large companies and small—is that our engineers actually get into the field. They go out with the customer and learn about the needs and the real use cases so we’re not trapped by thinking what we think is the best idea is really the best idea.”

Wilkinson also described Paragon’s strategy in breaking down the customer’s specific needs in order to get products to market.

“Often they’ve got a big list of what they want to do,” he said. “We try to narrow it down to the MVP, or minimal viable product. What do we have to get done today to get a product to market? What we find is that if you’ll do that minimal viable product, the customers will tell you where you need to pivot down the road.”

Wilkinson also discussed tech breakthroughs like 3D printing and shrinking surface mount technologies that have enabled Paragon to more easily innovate new solutions, why people’s perceptions regarding the outsourcing of engineering and developing services during the 90s were a hindrance to their initial growth, how fluctuations in economies and catastrophic events affect their company’s business, the ongoing growth of the Texas technology culture, and so much more. But you can only hear it by tuning into the podcast.

Bringing thought leadership to your morning routine, MarketScale Mornings host industry experts so that you stay informed of the newest trends, events and beyond in B2B. And for the latest thought leadership, news and event coverage across B2B, be sure to check out our industry pages.

Fly to the future each week with Drones In America.

For the latest news, videos, and podcasts in the IoT Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Direct-to-consumer telehealth raises spending, even as ASC investment surges

Direct-to-consumer telehealth raises spending, even as ASC investment surges

A Health Affairs analysis of commercial claims data (2011–13) found 12% of direct-to-consumer telehealth visits replaced visits to other providers and 88% represented new utilization, with net annual spending on acute respiratory illness increasing $45 per telehealth user. Separately, MobiHealthNews reported on August 31, 2026, via a HIMSSCast episode, that Erik Tellefson of Capital One said ambulatory surgery centers “represent one of the clearest growth structures in American healthcare.”

  • 01The most actionable benchmark for finance teams evaluating DTC telehealth is substitution rate, not visit growth. Health Affairs measured 12% substitution and 88% new utilization in commercial claims for acute respiratory illness.
  • 02The $45 per-user net annual spend increase in the Health Affairs analysis is small enough to hide in PMPM reporting but large enough to matter at scale, and it should be stress-tested against virtual-visit eligibility rules and repeat-use patterns.

Sep 2, 2026

HFMA’s new chair is a hospital CFO as Medicare reporting gets more detailed and revenue cycle work gets more technical

HFMA’s new chair is a hospital CFO as Medicare reporting gets more detailed and revenue cycle work gets more technical

HFMA named Corewell Health CFO Matthew E. Cox as its national chair effective June 1, 2026, while elevating revenue cycle and reimbursement leaders to its board, according to HFMA’s GlobeNewswire announcement. The association’s own coverage of CMS’s FY 2027 IPPS/LTCH PPS final rule summary and new Medicare cost-reporting requirements such as Worksheet S-12 indicates a compliance workload that is increasingly data- and documentation-heavy for hospital finance and reporting teams. In parallel, HFMA’s certification catalog, including the Certified Hospital Cost Report Specialist (CHCRS) and Certified Specialist Payment & Reimbursement (CSPR), points to how health systems are professionalizing the skill sets needed to operationalize reimbursement policy changes. For operators, the practical consequence shows up in staffing models, audit readiness, and the data plumbing needed to produce defensible cost reports and faster revenue cycle decisions.

  • 01HFMA’s board slate now visibly includes roles that control the work: a system CFO (Corewell Health) and a chief revenue officer overseeing $7 billion in patient revenue at Orlando Health, per GlobeNewswire. That’s a signal that cost reporting and revenue cycle execution are board-level concerns, not back-office chores.
  • 02Medicare cost reporting is moving toward more granular worksheets and documentation, and each new CMS reporting requirement becomes a data-integration project before it becomes a policy memo, per HFMA’s reporting on Worksheet S-12 and its FY 2027 IPPS/LTCH PPS coverage.
  • 03HFMA’s CHCRS, CRCR, and CSPR credentials provide a concrete way to benchmark internal capability: if cost report preparation, managed care contract terms, and prior auth workflows live in different teams, credentialing can reveal where handoffs are breaking down.

Sep 2, 2026

FDA QMSR ties supplier contracts to inspection prep

FDA QMSR ties supplier contracts to inspection prep

FDA’s Quality Management System Regulation (QMSR) took effect Feb. 2, 2026, incorporating ISO 13485:2016 into 21 CFR Part 820 and shifting inspections to a process-based model under Compliance Program 7382.850, according to MD+DI. That change is starting to show up outside the quality department: medical device OEMs are being pushed to spell out documentation, audit support, and change-control responsibilities in contract manufacturing agreements, as Medical Design and Outsourcing described. Two recent partnership moves, Ratio Therapeutics expanding radiopharmaceutical manufacturing with PharmaLogic in Idaho Falls and Menicon shifting U.S. Rose K manufacturing access to three partners after concluding a prior arrangement, illustrate how multi-party supply chains now need contract terms that map directly to integrated QMS evidence. The operational consequence is simple: under CP 7382.850, a complaint, supplier nonconformance, or process change can pull investigators across CAPA, risk management, purchasing, and design records in one thread, so contracts and quality records have to be built to travel together.

  • 01Under FDA CP 7382.850, inspection risk increasingly sits in the “handoffs” between complaint handling, CAPA, supplier controls, and the Risk Management File, so quality evidence has to be assembled end-to-end, not by department.
  • 02For OEMs outsourcing manufacturing, the most useful contract test in 2026 is whether each clause produces inspectable artifacts, who owns them, where they live, and how fast they can be produced during an audit.
  • 03Multi-partner manufacturing models, like Menicon’s three-partner Rose K availability and Ratio’s capacity expansion with PharmaLogic, raise the bar on configuration control, supplier risk classification, and change notification across sites.

Sep 2, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512